Rift Valley Fever virus - Epidemiology Flashcards
Where and when was RVFV first characterized?
In the Rift Valley of Kenya in 1930-1931 by Daubney and Hudson during an outbreak on a sheep farm.
Large Outbreaks: Kenya
1950-1951
1997-1998
2006-2007
Large Outbreaks: South Africa
1950-1951
1973-1975
2010-2011
Large Outbreaks: Egypt
1977-1979
1993
2003
Large Outbreaks: Middle East (Saudi Arabia & Yemen)
2000-2001
Large Outbreaks: Sudan
1973 (only animals)
2007-2008
Large Outbreaks: West Africa (Senegal & Mauritania)
1987
2022
Large Outbreaks: East Africa (Kenya, Sudan, Somalia, Tanzania)
1997-1998
2006-2007
Serologic evidence for RVFV maintenance in wildlife
High RVFV seroprevalence in wildlife during IEPs
Why do sheep and goats likely have lower seroprevalence during IEPs?
What does this mean?
High population turnover so more susceptible hosts during outbreak periods
What is the relationship between animal and human RVFV seroprevalence?
Few studies have addressed this question and none have considered the wildlife factor.
Human risk factors for RVFV seropositivity:
Increasing age
Sex: Male (likely occupational)
Regular contact with animals (butchering, milking, and sheltering)
Contact with aborted animal carcasses
Consumption of products from sick animals
Where and when was most of the RVFV serological data collected?
East Africa, namely Kenya during the 2000s.
Risk factors for severe RVF:
Data from Kenya shows association between contact with aborted tissues and severe RVF
HIV status is associated with encephalitic RVF (van Vuren, 2015).
What is the seroprevalence of humans?
Varies significantly depending on the region and year.
Meta analysis using data from 1999-2021 showed 0.15% (Madagascar) - 22% (Kenya) seropositivity during IEPs.